Xiaowei Hu
Assistant Professor, Public Health Sciences
PO Box 800717
Charlottesville, VA 22908
Bio & Overview
My research focuses on the development and application of statistical methods for 'omics prediction and 'omics risk score prediction of complex human diseases and traits. My main interests in human disease are chronic obstructive pulmonary disease (COPD) and interstitial lung disease. Additionally, I am actively working on other research areas including integrative analysis of GWAS with other 'omics (e.g., transcriptome-wide association study TWAS), post-GWAS analyses (e.g., statistical fine-mapping and colocalization), association studies (e.g., GWAS and epigenome-wide association study EWAS), and protein quantitative trait locus (pQTL) mapping study. Most of my published and ongoing works focus on developing and improving resources for diverse ancestry populations.
In addition to research projects, I have been actively engaged in two research communities, the NHLBI Trans-Omics for Precision Medicine (TOPMed) program and the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. I am a member of the MESA TOPMed Multi-Omics PrediXcan Working Group, TOPMed Pulmonary Function Population Cohorts Working Group, TOPMed Lung Working Group, MESA TOPMed Lung Working Group, and the TOPMed Multi-Omics Working Group. I am also the co-convenor of MESA TOPMed Multi-Omics PrediXcan Working Group.
Academic Information
- Department
- Public Health Sciences
Primary Education
- PhD, Statistics, Oklahoma State University, 2019
Other Affiliations
- Genomic Sciences
Research Interests
Research Disciplines
- Bioinformatics and Genomics
- Data Science in Medicine
- Genetics
- Statistics
- Translational Science
Selected Publications
Hu X, Kim JS, Saferali A, ..., Cho MH, Noth I, Manichaikul A. “Transcriptome-wide association study for Idiopathic Pulmonary Fibrosis survival identifies PTPN9 and SNRPB2”. American Journal of Respiratory and Critical Care Medicine (2024). PMID: 38626378.
Onengut-Gumuscu S, Webb-Robertson BJM, Sarkar S, Manichaikul A, Hu X, Frazer-Abel A, Holers VM, Rewers MJ, Rich SS. Genetic variants in the
complement system and their potential link in the aetiology of type 1 diabetes. Diabetes/Metabolism Research and Reviews (2024). PMID: 37649398.
Higbee DH, Lirio A, Hamilton F, ..., Hu X, ..., Smith GD, Tobin MD, Dodd JW. “Genome wide association study of Preserved Ratio Impaired Spirometry (PRISM)”. European Respiratory Journal (2024). PMID: 38097206.
Hu X, Logan J, Kwon Y, ..., Hughes TM, Garrett-Bakelman FE, Manichaikul A. “Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESA”. Scientific Reports (2023). PMID: 37848499.
Shrine N, Izquierdo AG, Chen J, ..., Hu X, ..., Wain LV, Hall IP, Tobin MD. “Multi-ancestry genome-wide association study improves resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk”. Nature Genetics (2023). PMID: 36914875.
Araujo DS, Nguyen C, Hu X, ..., Im HK, Manichaikul A, Wheeler HE. “Multivariate adaptive shrinkage improves cross-population transcriptome prediction and association studies in underrepresented populations”. Human Genetics and Genomics Advances (2023). PMID: 37869564.
Hill AC, Guo C, Litkowski EM, ..., Hu X, ..., Cho MH, Banaei-Kashani F, Bowler RP. Large scale proteomic studies create novel privacy considerations. Scientific Reports (2023). PMID: 37286633.
Hu X, Qiao D, Kim W, ..., TOPMed Lung Working Group, Cho MH, Im HK, Manichaikul A. “Polygenic transcriptome risk scores for COPD and lung function improve cross-ethnic portability of prediction in the NHLBI TOPMed program”. American Journal of Human Genetics (2022). PMID: 35385699.
Yang Z, MacDonald-Dunlop E, Chen J, ..., Hu X, ..., Reiner AP, Wilson JF, Shen X. “Genetic landscape of the ACE2 coronavirus receptor”. Circulation (2022). PMID: 35387486.